GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » EV-to-FCF

Proteomics International Laboratories (ASX:PIQ) EV-to-FCF : -10.81 (As of Mar. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Proteomics International Laboratories's Enterprise Value is A$59.59 Mil. Proteomics International Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-5.51 Mil. Therefore, Proteomics International Laboratories's EV-to-FCF for today is -10.81.

The historical rank and industry rank for Proteomics International Laboratories's EV-to-FCF or its related term are showing as below:

ASX:PIQ' s EV-to-FCF Range Over the Past 10 Years
Min: -58.74   Med: -14.29   Max: -4.3
Current: -10.58

During the past 10 years, the highest EV-to-FCF of Proteomics International Laboratories was -4.30. The lowest was -58.74. And the median was -14.29.

ASX:PIQ's EV-to-FCF is ranked worse than
100% of 415 companies
in the Biotechnology industry
Industry Median: 4.49 vs ASX:PIQ: -10.58

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-26), Proteomics International Laboratories's stock price is A$0.495. Proteomics International Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.055. Therefore, Proteomics International Laboratories's PE Ratio (TTM) for today is At Loss.


Proteomics International Laboratories EV-to-FCF Historical Data

The historical data trend for Proteomics International Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories EV-to-FCF Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.56 -38.02 -26.22 -14.18 -18.13

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -14.18 - -18.13 -

Competitive Comparison of Proteomics International Laboratories's EV-to-FCF

For the Biotechnology subindustry, Proteomics International Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteomics International Laboratories's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's EV-to-FCF falls into.


';

Proteomics International Laboratories EV-to-FCF Calculation

Proteomics International Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=59.588/-5.51
=-10.81

Proteomics International Laboratories's current Enterprise Value is A$59.59 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteomics International Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-5.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteomics International Laboratories  (ASX:PIQ) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Proteomics International Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.495/-0.055
=At Loss

Proteomics International Laboratories's share price for today is A$0.495.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteomics International Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.055.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Proteomics International Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories Business Description

Traded in Other Exchanges
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines